The population in Latin America is over 650 million, but accounts for only a fraction of the clinical research conducted worldwide. Leverage PanAmerican to access this population with less sites and more participants. PanAmerican ensures quality data with GCP trained investigators, smooth regulatory and customs approvals with in-country representatives, shorter timelines with experienced study startup operations and unique patient recruitment, and cost effectiveness commensurate with the region compared to the United States, European Union, or Asia-Pacific.